2018 annual financial data
BioRestorative Therapies 2018 Operating cash flow growth
Direct answer
Operating cash flow growth was -32.46%.
Operating income was -7,647,652 USD and net income was -12,517,803 USD.
Operating cash flow was -5,104,629 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 111,000 USD
- Operating income
- -7,647,652 USD
- Net income
- -12,517,803 USD
- Operating cash flow
- -5,104,629 USD